A Comparison of the Post-Marketing Safety of Four Selective Serotonin Re-Uptake Inhibitors Including the Investigation of Symptoms Occurring on Withdrawal

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1046/j.1365-2125.1996.00498.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Selective Serotonin Re-Uptake Inhibitors

2013English

Management of Side-Effects of Selective-Serotonin Re-Uptake Inhibitors

Current Psychopharmacology
PsychiatryMental HealthPharmacology
2018English

BOOK REVIEWS: Selective Serotonin Re-Uptake Inhibitors Perspectives in Psychiatry Vol. 1.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1991English

The Role of Fluoxetine and Selective Serotonin Re-Uptake Inhibitors in Motor Recovery Following Acute Ischaemic Stroke

European Neurological Review
Neurology
2011English

Dose-Response Relationship Between Selective Serotonin Re-Uptake Inhibitors and Injurious Falls: A Study in Nursing Home Residents With Dementia

British Journal of Clinical Pharmacology
Pharmacology
2012English

Selective Serotonin Reuptake Inhibitors.

BMJ
1992English

Selective-Serotonin Reuptake Inhibitors for the Treatment of Hypersensitive Esophagus

Therapeutic Advances in Gastroenterology
Gastroenterology
2011English

Selective Serotonin Reuptake Inhibitors Induced Serotonin Syndrome –A Case Report

International Journal of Hospital Pharmacy
2017English

Selective Serotonin Reuptake Inhibitor Add-On Therapy for the Negative Symptoms of Schizophrenia

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy